Real-time enrollment status for this locally advanced or metastatic non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:38 PM UTC
| NCT Number | NCT04686305 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 304 participants |
| Active Locations | 13 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of October 12, 2026: Clinical trial NCT04686305 is currently recruiting participants. This phase1 study for locally advanced or metastatic non-small cell lung cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04686305 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04686305 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.